genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2014
Insomnia
News
Statins Wrongly Blamed for Most Side-Effects, Says Metastudy
News
Paladin Seals $5.5M Cash and Equity Agreement for Somaxon’s Insomnia Drug
News
Zhejiang Jingxin to Develop Evotec’s Clinical-Stage Insomnia Candidate in China
News
FDA Clears Shionogi’s Nonstimulant ADHD Therapy
Drug Discovery
Alexza to Obtain $16.4M in Registered Direct Offering
News
Purdue Pays $25M for U.S. Commercialization Rights to Transcept’s Insomnia Drug
News
Evotec Cuts Workforce with New Focus on Forging Discovery Partnership
News
Orexo Receives FDA Green Light for Insomnia Drug
News
The Biggest R&D Collaboration Spenders in 2008
News
Novacea Inks Merger Agreement with Transcept
1
2
3
Page 2 of 3
Scroll Up
Scroll Up
